Results 51 to 60 of about 2,451,260 (295)

Cytomegalovirus: A tale of resistance [PDF]

open access: yesMedicinski Podmladak, 2019
Cytomegalovirus (CMV) is a pathogen that affects the majority of the world's population. It may exhibit a wide spectrum of clinical manifestations, ranging from asymptomatic infection in the healthy, congenital disease of the new-born to downright life ...
Janković Marko, Jovanović Tanja
doaj  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm [PDF]

open access: yes, 2013
The induction of an interferon-induced antiviral state is a powerful cellular response against viral infection that limits viral spread. Here we show that a pre-existing antiviral state inhibits replication of influenza A viruses in human A549 cells by ...
Xiao, Han   +6 more
core   +1 more source

Reversion of Val(Ganciclovir)-Resistance-Associated Mutations in Two SOT Patients with Mismatched Serostatus for CMV (D+/R-)

open access: yesViruses
The emergence of drug-resistant cytomegalovirus (CMV) complicates viral response to therapy. We present two cases of solid organ transplant (SOT) recipients, highlighting the reversion of UL97 mutations associated with val(ganciclovir) resistance ...
Elena Seminari   +9 more
doaj   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

open access: yesMolecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim   +7 more
wiley   +1 more source

Optimal Treatment Rate During an Influenza Pandemic in the Presence of Drug-Resistance Emergence [PDF]

open access: yes, 2008
The problem was posed by Seyed Moghadas, from the National Research Council Institute for Biodiagnostics in Winnipeg, Manitoba. It concerns the optimization of the rate of treatment with antivirals during a pandemic of influenza, to achieve the following
Arino, J.
core  

Molecular mechanisms of insulin resistance in chronic liver disease [PDF]

open access: yes, 2008
The work presented here analyses the role of PP2A in the dysregulation of glucose metabolism in the setting of chronic hepatitis C. We propose a new model for virus induced insulin resistance development through the overexpression of PP2A in the liver ...
Bernsmeier, Christine
core   +1 more source

From energy provision to protein synthesis: Tunnelling nanotubes as mediators of intercellular metabolic cooperation in cancer

open access: yesFEBS Open Bio, EarlyView.
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley   +1 more source

Epidemiological consequences of household-based antiviral prophylaxis for pandemic influenza [PDF]

open access: yes, 2013
Antiviral treatment offers a fast acting alternative to vaccination; as such it is viewed as a first-line of defence against pandemic influenza in protecting families and households once infection has been detected.
M. J. Keeling   +15 more
core   +1 more source

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure

open access: yesViruses, 2016
Chronic hepatitis C is a major cause of chronic liver disease, including liver cirrhosis and hepatocellular carcinoma. The development of direct-acting antivirals (DAAs) revolutionized hepatitis C virus (HCV) treatment by offering genuine prospects for ...
Che C. Colpitts, Thomas F. Baumert
doaj   +1 more source

Home - About - Disclaimer - Privacy